Clinical Trials Browser

Phase 1 × OTHER × magrolimab × Clear all

NCT05169944 2025-07-09

PNOC025

Phase 1 Completed

Brain Neoplasms

NCT05823480 2024-09-19

Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS

Phase 1 Withdrawn

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute